Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	A-AZD7325 2 mg	107
Overall Study	STARTED	B-AZD7325 5 mg	106
Overall Study	STARTED	C-AZD7325 10 mg	105
Overall Study	STARTED	D-Placebo	106
Overall Study	COMPLETED	A-AZD7325 2 mg	90
Overall Study	COMPLETED	B-AZD7325 5 mg	91
Overall Study	COMPLETED	C-AZD7325 10 mg	83
Overall Study	COMPLETED	D-Placebo	90
Overall Study	NOT COMPLETED	A-AZD7325 2 mg	17
Overall Study	NOT COMPLETED	B-AZD7325 5 mg	15
Overall Study	NOT COMPLETED	C-AZD7325 10 mg	22
Overall Study	NOT COMPLETED	D-Placebo	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00808249/flow